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Toxin-antitoxin systema b s t r a c t
ADP-ribosylation is an ancient posttranslational modification present in all kingdoms of life. The system
likely originated in bacteria where it functions in inter- and intra-species conflict, stress response and
pathogenicity. It was repeatedly adopted via lateral transfer by eukaryotes, including humans, where it
has a pivotal role in epigenetics, DNA-damage repair, apoptosis, and other crucial pathways including
the immune response to pathogenic bacteria and viruses. In other words, the same ammunition used
by pathogens is adapted by eukaryotes to fight back. While we know quite a lot about the eukaryotic sys-
tem, expanding rather patchy knowledge on bacterial and viral ADP-ribosylation would give us not only a
better understanding of the system as a whole but a fighting advantage in this constant arms race. By
writing this review we hope to put into focus the available information and give a perspective on how
this system works and can be exploited in the search for therapeutic targets in the future. The relevance
of the subject is especially highlighted by the current situation of being amid the world pandemic caused
by a virus harbouring and dependent on a representative of such a system.
 2021 The Author(s). Published by Elsevier B.V. on behalf of Research Network of Computational and
Structural Biotechnology. This is an open access article under the CC BY-NC-ND license (http://creative-
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Post-translational modifications (PTMs) introduce enormous
versatility to the genome-encoded proteome. By altering localiza-
tion, activity, stability and interaction partners of proteins it pro-
vides means to multitask even a more restricted menu of
proteins (bacteria code for an average of 3200, viruses for around
42 proteins; in comparison to more than 15 000 in eukaryotes)
[1]. The human ADP-ribosylation system has been the focus of
most studies, but it is becoming obvious that bacterial and viral
repertoire does not fall short of diversity and candidates, that could
also be targeted for therapeutic purposes. On a physiological level,
it enables microorganisms (and viruses) to adapt to the changes in
their environment - be it a difference in availability of resources,
presence of intra- and interspecies toxins, or used as a weapon that
neutralizes the host defences or simply hijacks the host’s
resources.
The ADP-ribosylation PTM entails the transfer of one or more
interlinked molecules of ADP-ribose (ADPr) moieties from redox
cofactor b-nicotinamide adenine dinucleotide (NAD+) onto nucleic
and amino acid side chains with nucleophilic oxygen, nitrogen, or
sulphur, resulting in O-, N-, or S-glycosidic linkage to the ribose,
and a phosphodiester bond with O- on aspartate and glutamate
or small molecules such as antibiotics (Fig. 1). The system consists
of ADP-ribosyl transferases (ARTs) that covalently attach the ADPr
onto targets and the ADP-ribosyl hydrolases (ARHs) which cleave
off the ADPr. The majority of ARTs catalyse the transfer of a single
ADPr onto the target. Only a few members of the poly-ADPr poly-
merase (PARP) family can synthesize long chains of poly-ADPr
(PAR). For conciseness, we will call the mono-ADP-ribosylation -
MARylation and the addition of poly-ADPr - PARylation. Based on
the chemical nature, length and complexity of the ADPr-target
bond, different enzymes are needed to reverse it. The hydrolysis
of the ADPr from the target is achieved by two evolutionarily and
structurally distinct protein families of ARHs – the macrodomain
and the DraG-like hydrolases.
Proteins involved in the ADP-ribosylation cycle are unevenly
distributed among bacteria, with ARHs being more abundant than
ARTs. There are bacterial species limited to very few ART or ARH
homologues or just one of the specialized reversible systems (e.g.
pathogenic bacteria). On the other hand, there are bacteria with
a complete repertoire of ART/ARH homologues that can use ADP-
ribosylation in its entirety (Table 3).
Based on the available data and phylogenetic analysis, the ADP-
ribosylation has emerged as a part of the bacterial conflict/stress-
response system and was taken up by the eukaryotes from the last
universal common ancestor. There are indications that it was also
later exchanged in both directions via lateral transfer [2–4]. Part of
the reason for this constant exchange and evolution is the selective
pressure between the pathogenic bacteria and viruses versus host2367immune system, both utilizing ADP-ribosylation enzymes as
ammunition. The typical pathogenic bacterial ARTs act as toxins
and numerous viruses manipulate host PTMmachinery, to regulate
their replication or evade host immunity response. It is thought
that both the pathogens and the eukaryotic host innate immune
system often obtain compensatory mutations to gain the advan-
tage in this constant arms race [5–8].
Still, ADP-ribosylation in bacteria fulfils important endogenous
functions which are still poorly understood. Some examples come
from studying sporulation in Bacillus subtilis [9], development and
cell–cell interaction in Myxococcus xanthus [10–12], but best evi-
dence comes from Streptomyces species [13–16]. Streptomyces are
soil-dwelling Gram-positive bacteria that are best known for their
large genome (S. coelicolor codes for almost 8000 proteins [17]) and
a complex life cycle that includes morphological differentiation
and the production of various secondary metabolites including
antibiotics, anti-cancer drugs and immunosuppressors. Over the
last 30 years, ADP-ribosylation was found to be involved in growth,
differentiation and secondary metabolite production in S. griseus
and S. coelicolor [13–14,16,18–21]. S. coelicolor possesses enzymes
from essentially each ADP-ribosylation metabolism family (Tables
1, 2 and 3) and are therefore an appropriate system to study the
breadth of the bacterial ADP-ribosylation system.
Many excellent reviews about the ADP-ribosylation systems
have been written [2–3,12,6–8,22–27], but a comprehensive over-
view of the ART/ARH system with a focus on bacteria and viruses is
long overdue. In the course of this review, we will analyse each
group and try to shine some light on their particularities based
on the structural, biochemical and functional data available.2. ADP-ribosyl transferases
The ART superfamily can be divided into two major structurally
and functionally different families based on their founder trans-
ferase: the Diphtheria toxin (DTX) and the Cholera toxin (CTX)
family [2,22,28]. We will also discuss a group of structurally unre-
lated NAD+-dependent deacetylase with some members showing
robust ART activity - sirtuins [29] (Table 1).
Despite the primary sequence diversification, the ARTs share a
common structural organization pattern: an N-terminal portion
(with highly conserved histidine in DTX, or arginine in CTX)
responsible for NAD+-binding; and a C-terminal portion with a
highly acidic region with a conserved glutamate residue crucial
for the cleavage of NAD+ via the SN1 reaction mechanism. Mutation
of this key glutamate residue results in a several hundred-fold loss
of ART activity and cytotoxicity [22,30]. The common 3D core is
formed by six strands, most of which are followed by a down-
stream helical element [2]. The NAD+ binds to the hydrophobic
cleft formed within the core (Fig. 3). Most of the ARTs have three
Fig. 1. Summary of ADP-ribosylation pathways with enzymes and their main targets - proteins, nucleic acids and antibiotics. Structures of important substrates and
products are shown in the legend.
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Table 1
Bacterial and viral ARTs.
ND stands for a non-defined domain.
Table 2
Bacterial and viral ARHs.
P. Mikolčević, A. Hloušek-Kasun, I. Ahel et al. Computational and Structural Biotechnology Journal 19 (2021) 2366–2384
2369
Table 3
Distribution of ART and ARH homologues in different bacterial species.
Bacterial species are representatives of several bacterial phyla: Proteobacteria (red), Actinobacteria (blue), Firmicutes (green), Deinococcus-Thermus (violet), Fusobacteria,
Chloroflexi and Thermotogae, respectively. Pathogenic bacteria are marked with a star. Proteins are designated with UniProt accession numbers.
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E in the CTX family. The characteristic trio became the motif by
which other ARTs are designated to the particular family, although
their catalytic residues still might differ (Table 1, Figs. 2 and 3).
Bacterial ARTs were originally discovered as toxins, with the
ability to irreversibly modify the host’s single target protein on a
defined residue with high specificity (Table 1). The host targets
are usually the key regulators of cellular function and interference
in their activity, caused by ADP-ribosylation, leads to serious
deregulation of key cellular processes and eventual cell death.
The vast majority of bacterial and viral ARTs are enzymes that
can MARylate their targets, but some DTX ARTs have PARylation
activity (PARPs). The specificity of bacterial ARTs is still an ongoing
issue, but there is evidence that the CTX family has a structural ele-
ment - ADP-ribosylating toxin turn-turn (ARTT) loop with eight
residues motif X-X-u-X-X-E/Q-X-E (u stands for either of aromatic
residues (Phe, Trp, or Tyr)) defining the substrate recognition site.
DTX family lacs the ARTT loop, so their substrate recognition site is
still elusive (the subject is reviewed in [27]).
Of note is that despite the notoriety of many ARTs acting as tox-
ins that participate in pathogenicity, many diphtheria- and
cholera-like toxins are being used in a variety of novel therapeutic
(e.g. targeted drug delivery) and basic science applications (sum-
marized in [22]).23702.1. Diphtheria toxin family ARTs
The founder of the DTX family is responsible for the lethality of
Corynebacterium diphtheria, the pathogenic bacterium that causes
diphtheria. Alternatively, this family is therefore also called ARTD
[31]. These ARTs have a comparatively broad target range with
acidic (glutamate/aspartate), thiol (cysteine), and hydroxyl
(serine/tyrosine)-containing residues among others being
described as acceptors [32–37].
The typical DTX family ART fold is augmented by C-terminal
extension [2]. The key glutamate is sitting in [QED] sequence.
The position of this sequence is suggested to play a role in recogni-
tion of the target moiety that is being ADP-ribosylated [38–40].
The DTX family consist of classical toxins, closely related to the
original DTX, the family of bacterial PARPs and bacteria-specific
antibiotic inactivating ARTs.
2.1.1. Diphtheria and diphtheria-like toxins
The classical DTX and closely related toxins are scarcely repre-
sented among bacterial genomes [41] ~60 kDa ARTs consisting of
three structural domains of equivalent sizes: the catalytic (C)
domain forming the fragment A and the translocation or trans-
membrane (T) domain which with the receptor-binding (R)
domain, forming the fragment B [42] (Table 1).
Fig. 2. Protein sequence alignments of ART and ARH representatives. ART alignments include partial sequences of diphtheria (DTX) and cholera (CTX) toxins, PARPs from
Herpetosiphon aurantiacus (HaPARP), Clostridioides difficile CD160 (CdPARP), Butyrivibrio proteoclasticus (BpPARP), Mycobacteroides abscessus (MaPARP), Arr from
Mycobacterium smegmatis (MsArr) and its homologue from Streptomyces coelicolor (SCO2860), Scabin from Streptomyces scabiei, the mosquitocidal toxin from Lysinibacillus
sphaericus (LsMTX), viral ARTs Alt and ModA from Escherichia virus T4 and AcrIF11 from Pseudomonas aeruginosa PA14 (PaAcrIF11), Tre1 from Serratia proteamaculans
(SpTre1), DraT from Rhodospirillum rubrum (RrDraT), SdeA from Legionella pneumophila (LpSdeA), Tpt1 from Clostridium thermocellum (CtTpt1) and S. coelicolor (SCO3953),
ParT from Sphingobium sp. (SsParT) and DarT from Thermus aquaticus (TaDarT). ARH alignments include partial sequences of PARGs from Thermomonospora curvata (TcPARG)
and Deinococcus radiodurans (DrPARG), MacroD-like proteins from Escherichia coli (EcYmdB), Oceanobacillus iheyensis (OiMacroD), S. coelicolor (SCO6450) and SARS-CoV-2
virus (SC2MacroD), DarG from T. aquaticus (TaDarG), TARG1 from Fusobacterium mortiferum (FmTARG1) and SCO6735 from S. coelicolor and DraG-like proteins from
Rhodospirillum rubrum (RrDraG) and Serratia proteamaculans (SpTri1). Amino acids in motifs characteristic for particular ART/ARH groups are framed.
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(ExoA) and Cholix toxin from Vibrio cholerae [22] all exclusively
modify eukaryotic GTP-binding elongation factor 2 (EF2), a protein
essential for protein synthesis. The specific target is the intracyclic
NH in diphthamide (Fig. 1), a post-translationally modified
histidine residue, found in EF2 in archaea, yeast and mammals
(diphthamide 715 [43]). The diphthamide is positioned close to
the anticodon recognition domain of EF2 and the region interacting
with the P-site of the ribosome, so the ADPr probably causes steric
hindrances leaving EF2 unable to achieve key interactions and fulfil2371its function [22,44]. Consequently, EF2 halts protein production
entirely and leads to cell death. The ADP-ribosylation of EF2 is irre-
versible and cannot be rescued by any endogenous mechanism in
the cell [45].
The DTX active site is located in C-domain and positioned in a
cleft formed by three b-strands, a-helix and a flexible loop CL2.
In this cleft, His21 and Tyr65 are implicated in NAD+ binding and
Glu148 plays a key role in catalysis [42] (Fig. 3A). The well-
ordered CL2 loop extends over the active site but becomes disor-
dered upon NAD+ binding. This allows better positioning of
Fig. 3. 3D structures of diverse bacterial ARTs. (A) DTX:NAD complex - CL2 loop (res 34–52) is shown in green; (B) M. smegmatis rifampin ART in complex with rifampin
(blue); (C) C. thermocellum Tpt1 in complex with ADPr analogue (yellow); (D) C. crescentus CC0527 (E) CTX - ‘‘activation loop” and ‘‘active site loop” are shown in dark blue and
cyan, respectively; (F) S. scabies Scabin toxin in the complex with NADH - missing Tyr128 was built using UCSF Chimera, amino acids important for DNA binding are shown in
yellow; (G) L. sphaericus MTX - missing loop was built using Swiss Model; (H) T. maritima Sir2 in complex with ADPr (yellow) and an acetylated p53 peptide (olive green),
important His116 mutated to alanine was built with UCFS Chimera. (I) S. pyogenes SirTM in complex with NAD - Zn2+ ion is depicted as ball model in blue; (J) A. tumefaciens 6b
apoprotein - missing flexible loop was built with Swiss Model; (K) Sphingobium sp. ParT toxin. Key catalytic residues are shown as a stick model in green. NAD+ and its
analogues are shown in magenta. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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charged diphthamide moiety stabilised and coordinated during
the ART reaction [40]. The ADP-ribosylation reaction has been
proposed to proceed by a direct displacement reaction, with the
p-imidazole nitrogen of diphthamide being activated by
Glu148 for nucleophilic attack on the N-glycosidic bond of NAD+
[42].
A small divergent group of DTX-like ARTs comprising of
Salmonella bongori SboC/SeoC and Escherichia coli EspJ show
activity towards Src (Glu310) and Csk (Glu236) host kinases
[46–47]. The MARylation of the two kinases inhibits the phagocytic
killing of bacteria by the host cell allowing their persistence in the
susceptible host [47]. Of note is that the mART activity of EspJ is
linked to its simultaneous amidation activity [46]. The EspJ and
SboC/SeoC seem structurally similar to Pseudomonas syringae
(plant pathogen) AvrPphF effector protein which instead of the
key catalytic histidine and glutamate, has Arg72 (Arg79 in SboC/
SeoC) and Asp174 (Asp187 in SboC/SeoC) which could participate
in the catalytic activity [48–49].
2.1.2. Bacterial PARPs
Bacterial PARPs are the only DTX family ARTs that have PARyla-
tion activity. Many bacterial species possess proteins essential for a
functional PAR metabolism (Table 3) that were probably gained
through horizontal gene transfer [4,50]. The human PARP1 and bac-
terial PARPs from Herpetosiphon aurantiacus and Clostridiodes diffi-
cile seem, indeed, structurally very similar [3,50]. Bacterial PARPs
consist of maximum three domains – the N-terminal tryptophan-
glycine-arginine (WGR) domain which is important for DNA-
dependent activation, the mid-portion with an a-helix allosteric
regulation domain (PARP_reg), followed by the ART domain (PARP)
with the conserved catalytic glutamate (Table 1). The seventy-two
sequences containing at least the PARP catalytic domain are found
distributed in six bacterial phyla (Actinobacteria, Bacteriodetes,
Choloflexi, Cyanobacteria, Firmicutes, and Proteobacteria). Most of
these contain the catalytic and WGR domains without a well-
defined regulatory domain, although the presence of a helical
domain in their 3D predicted structures might fulfil the role [50].
Nevertheless, there is little evidence of actual bacterial PARP
activity. Tangible evidence of endogenous PARP activity comes
from Deinococcus radiodurans where the presence of endogenous
PAR was shown [51]. Also, the PAR signal strength was signifi-
cantly increased when D. radiodurans culture was supplemented
with NAD+ or PARG gene was deleted, indicating that the PARyla-
tion depends on the NAD+ availability/metabolism. However, no
protein has been identified to be responsible for this activity. PARP
activity in vitro has been shown for two bacterial PARPs from Her-
petosiphon aurantiacus and Clostridiodes difficile CD160 [4,50]. HaP-
ARP is sensitive to the PARP inhibitor KU-0058948 and required
DNA for its activation [4], which is in line with the human PARP
characteristics. CdPARP was proven to be highly active in vitro.
Also, the PARylation by CdPARP and HaPARP was reversed by their
corresponding PAR-glycohydrolases as evidence of functional PAR
systems in C. dificile C160 and H. aurantiacus [4,50].
2.1.3. Rifampin ARTs
Rifampin ARTs (also called Arr) can be found in the genomes of
pathogenic and non-pathogenic bacteria [52]. Arr ADP-ribosylates
the hydroxyl group of rifampin (Fig. 1). This modification inacti-
vates rifampin, an antibiotic mainly used for treating tuberculosis
and infections caused by multidrug-resistant Staphylococcus aur-
eus. Shin et al metagenomics study on the distribution of the Arr
gene in search for novel resistant bacterial strains, is a good exam-
ple of how useful the knowledge on bacterial ARTs can be [52].
Arr is an unusually small enzyme (~16 kDa) and does not have
any obvious sequence conservation with known ARTs. Structurally,2373it folds similarly to DTX, but the key glutamate residue in the con-
served motif H-Y-E is replaced by an aspartate residue (Table 1 and
Fig. 2). It is composed of two antiparallel b-sheets and two a-
helices. The two a-helices form the walls of a deep rifampin-
binding cleft (Fig. 3B). The second helix (a2) forms a C-terminal
loop extension providing a cap over the active site which ensures
overall wrapping of the C-terminal region around the core domain
and rifampin binding. Given the limited contact that a2 makes
with the rest of the protein, it is likely that this helix would be
unstructured in the absence of rifampin. Interestingly, the crystal
structure revealed that rifampin does not make any H-bonds with
the active site, its binding is mainly electrostatic. It is suggested
that the reaction mechanism proceeds through an oxocarbenium
transition state stabilised by Asp84 and formed after releasing
nicotinamide. This enables the attack of the hydroxyl group at
antibiotic C23 atom to the C1 atom of the distal ribose [38].
The lack of direct interactions of rifampin with Arr, the Arr
broad specificity and broad Arr gene distribution in microbial gen-
omes, suggests that the function of Arr against rifampin is only a
secondary function [38]. In the study of non-pathogenic environ-
mental mycobacteria, Mycobacterium smegmatis Arr is shown to
be involved in DNA damage response, reactive oxygen species for-
mation during exponential growth and biofilm formation [53–55].
Streptomyces coelicolor also has a rifampin-inactivating Arr homo-
logue, the SCO2860 protein [38].
2.2. Cholera toxin family ARTs
The best known bacterial toxin from this group is the infamous
CTX from Vibrio cholerae, a reason why this group is alternatively
called the ARTC group [31]. The active site of the CTX family is
characterized by the R-S-E triad which is seen in several bacterial
toxins and bacteriophage ARTs (discussed below) (Table 1). The
arginine positions NAD+ in the active site and the [STS] motif (en-
compassing the serine in R-S-E) stabilizes the NAD+-binding
pocket. The invariant glutamate positions the NAD+ molecule to
promote hydrolysis, like in the DTX toxins. The CTX family MARy-
lates arginine, lysine, cysteine, aspartate and asparagine [56–60]
(examples mentioned below). A small group of guanine-specific
ADP-ribosylating toxins found in cabbage butterfly and some
insecticidal and soil-dwelling bacteria target DNA instead [61–65].
2.2.1. Cholera and cholera-like toxins
CTX and closely related toxins are, as DTX toxins, scarcely rep-
resented in bacterial genomes and come in three types of struc-
tural–functional organisations.
The first group, the typical cholera toxins, include CTX, the heat-
labile enterotoxin from Escherichia coli [66] and the pertussis toxin
from Bordetella pertussis [67–68]. They are two-chain proteins
(Mr = 85,6 kDa), with an enzyme component A, and a nontoxic host
receptor-binding component B. The group is structurally distin-
guished by a long loop which helps to anchor the catalytic subunit
into the B pentamer during toxin delivery.
Activation of the enzymatic A subunit requires proteolytic
cleavage between residues 192 and 194, reduction of a single disul-
phide bond (Cys187 - Cys199) which holds the nicked A subunit
together, and a subsequent gain in flexibility of an ‘‘active site
loop” which occludes active site by interacting with an ‘‘activation
loop” [69–71] (Fig. 3E). ‘‘Active site loop” increased flexibility leads
to an open conformation and permits entry of the NAD+ and the
target arginine residue [72]. The substrate of these toxins is the a
subunit of the heterotrimeric G-protein (CTX modifies Arg201, per-
tussis toxin modifies Cys347 and E. coli toxin targets Lys345 and
Asn347) [56,73]. MARylation locks the G protein in a GTP-bound
state, which constitutively stimulates host adenylate cyclase and
causes efflux of the chloride ions together with water causing the
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Glu110 are implicated in substrate binding and Glu112 is a cat-
alytic residue that likely participates in the formation of an
oxocarbenium-like intermediate of NAD+ that is capable of reacting
with an incoming nucleophile [74]. Two mutually similar toxins
from Salmonella serovar Typhi (typhoid toxin) [75] and Typhimur-
ium (ArtAB toxin) [49,76–77] share structural similarity to pertus-
sis toxin, but show some dissimilarity in the structural
organization (typhoid toxin incorporates domains with nuclease
and ART activity) and symptoms (ArtAB, unlike pertussis toxin,
does not induce leukocytosis [76]), and would therefore be an
interesting subject for future studies.
The second type of CTX-like toxins from pathogenic Clostridium
botulinum, Clostridium perfringens (iota toxin) [78] and facultative
pathogen Bacillus cereus (certhrax) [79] have a catalytic domain
and receptor binding domain which are expressed separately and
interact on the surface of the host cells. They target monomeric
G-actin at Arg177 which inhibits actin polymerization, causes
cytoskeleton breakdown and cell death [22]. These ARTs often
come in operons with immunity proteins which suggests a role
in both intra-bacterial and bacterio-eukaryotic conflicts [80].
The third and smallest type of CTX-like toxins includes Staphy-
lococcus aureus C3stau2 [81], C. botulinum C3bot [82] and Pseu-
domonas aeruginosa ExoS [83] which consist only of the catalytic
domain. C3 toxin-mediated MARylation occurs on Asn41 of small
Rho GTPases, which also play a role in cytoskeleton dynamics
and gene expression. This MARylation does not inhibit the Rho pro-
teins but sequesters them to the cytoplasm and therefore makes
some of the usual interactions inaccessible [22].
2.2.2. Pierisins
Pierisin and the pierisin-like ARTs are a small group of CTX fam-
ily toxins that mainly target DNA. The founder, pierisin, is found in
the cabbage butterfly species, Pieris rapae, where it seems to act
antagonistically towards the non-habitual parasitoids [61,64]. Pier-
isin MARylates the N2 atom of guanine bases of dsDNA, causing
apoptosis of the target cell [61,84–85].
Scabin from Streptomyces scabies (a soil-dwelling plant patho-
gen) is a 22 kDa single-domain enzyme that shares 40% sequence
identity with pierisin, but it lacks the pierisin-characteristic Ricin
B-like domain and the auto-inhibitory linker (Table 1, and exempli-
fied by MTX explained below and in Fig. 3G), suggesting a different
regulatory mechanism [86]. Scabin was shown to MARylate the
exocyclic amino group on guanine bases and most of its derivatives
in either single-stranded or double-stranded DNA [86–87]. The
Trp128 and Tyr129 bind DNA substrate by interacting with adja-
cent nucleotides to the guanine nucleophile, allowing Trp155 to
dock the target guanine base making it required for transferase
activity (Fig. 3F) [87,199]. Glu160 stabilizes the oxocarbenium ion
intermediate, while Gln158 positions guanine N2 exocyclic amine
for nucleophilic attack on C10 atom of NAD+ distal ribose [87–88].
S. coelicolor pierisin-like ART SCO5461 (ScARP) shares a high
structural similarity with Scabin (RMSD = 0.484 Å) and has 78.4%
sequence identity. Amino acids important for Scabin catalysis are
also present in SCO5461, therefore, the same catalytic mechanism
is proposed [89]. It is predicted to be a transmembrane protein
with a transmembrane domain (T) and an extracellular catalytic
domain (Enterotoxin_a; Table 1). SCO5461 MARylates primarily
guanosine and most of its derivatives, as well as yeast tRNA [63],
and can be auto-modified on Asp161 [21]. Depletion mutant
showed pleiotropic conditional defects in morphological differenti-
ation, sporulation, and highly increased production of antibiotic
actinorhodin [15].
Protein-modifying pierisin homologue with 31% sequence iden-
tity to pierisin is the mosquitocidal toxin from Lysinibacillus sphaer-
icus (an insect pathogen), also called MTX. It is structurally rather2374well studied ~97 kDa single-chain toxin with an N-terminal cat-
alytic ART domain (Enterotoxin_a) and C-terminal putative Ricin
B-like domains typical for pierisin and similar ARTs (Table 1,
Fig. 3G) [200]. The linker between the two domains has an inhibi-
tory function, and the MTX can be activated by proteolytic cleavage
which, in vivo, occurs in the host mosquito larval gut [65]. Heterol-
ogous expression of MTX in E. coli yielded several MARylated pro-
teins, out of which one was the translation elongation factor EF-Tu
(on undetermined arginine residue). The MARylation of EF-Tu pre-
vents the ternary complex formation of EF-Tu, GTP, and aminoacyl-
tRNA, resulting in inhibition of bacterial protein synthesis [90].
MTX shares a characteristic [EXE] catalytic motif (Fig. 3G) common
in other arginine-modifying ARTs [60,88].2.2.3. Viral ARTs
The three known viral ARTs produced by the T4 bacteriophage -
Alt, ModA and ModB, belong to the CTX family (Table 1 and Fig. 2).
The well-ordered production of T4 is achieved by sequential activa-
tion of three different classes of promoters and at the post-
transcriptional level. The latter relies on the coordinated ADP-
ribosylation activity of the three T4 ARTs. The Alt acts immediately
after infection and modifies at least 27 E. coli proteins [91], includ-
ing one of the a-subunits of the RNA polymerase, EF-Tu (mentioned
in MTX section above) and MazF at Arg84 (a part of the E. coli toxin/
antitoxin (TA) system) inhibiting its endonuclease activity. MazE/
MazF TA is suggested to be a part of the E. coli antiphage defence
system as the growth of T4 phage was significantly increased by
the disruption of mazE-mazF genes [92]. ModA modifies both a-
subunits of the host RNA polymerase at Arg265, reducing its activ-
ity [93]. ModB targets ribosomal S1 protein, EF-Tu and six other
proteins [91]. Joined MARylation of translation apparatus (EF-Tu,
S1 and others) by Alt and ModB likely contribute to the immediate
shut-down of host mRNA translation during T4 infection [91–94].
A novel type of bacteriophage AcrIF11 mART was recently iden-
tified as a part of the anti-CRISPRs (Acrs) system, which acts as a
protein-based inhibitor able to inactivate the bacterial CRISPR-
Cas immune system. Crystal structure of AcrIF11 revealed the best
fit with the catalytic domain of DTX, but instead of the H-Y-E motif,
only the His residue was conserved (His7), while the tyrosines and
catalytic glutamate are replaced by Phe26, His37, and Asp115,
respectively (Fig. 2). This newly discovered ART domain has not
been annotated yet (Table 1). It is shown that D115A mutation
leads to a complete loss of ADP-ribosylation, but does not com-
pletely inhibit NAD+ binding, suggesting that D115 is essential dur-
ing the catalytic process. This is in agreement with the same spatial
positioning of D115 as core catalytic Glu residues in known bacte-
rial ARTs (Fig. 3). Inhibitory action of AcrIF11 is achieved through
MARylation of the Asn250 residue of the Cas8f subunit of the Csy
complex. This completely abolishes its dsDNA binding activity
and consequently inactivates the CRISPR system. Interestingly,
for substrate recognition, the whole complex composed of nine
Cas proteins (Cas5f, Cas6f, Cas8f, and six Cas7f proteins) and a sin-
gle 60-nt crRNA (CRISPR RNA) is required. Specific double mutation
within the Cas7f subunit (K58A/K60A) render the Csy complex
resistant to ADP-ribosylation by AcrIF11, while single mutations
markedly diminish this modification [95]. This system exists in
lysogenic Pseudomonas aeruginosa PA14 and in more than 50 other
Proteobacteria species.2.3. Divergent ARTs
2.3.1. Tpt1/KptA and CC0527 ARTs
Tpt1 (tRNA 20-phosphotransferase) (also known as KptA in
E. coli) is one of the most represented lineages in the ART super-
family (Table 3)(reviewed in [96]). Due to its distribution and sim-
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likely evolved in bacteria and was then transferred to archaea
and eukaryotes, independently [2]. In yeast, it is essential for the
maturation of tRNA, by adding the ADPr to the 20-phosphate, which
is exposed after the tRNA splicing and RNA ligase action, following
the intron removal [97]. Since bacteria lack introns, its function
here is much less obvious. In some bacterial operons, it comes with
the RNA repair 50 ? 30 polymerase Thg1, which suggests a role in
RNA repair. In several bacteria, it comes as a part of NAD+/ADPr
metabolism operons (with, for example, sirtuins, macrodomains,
ARHs, NADAR (NAD+ and ADPr domain) etc.), but none of the
RNA-related genes [73] which indicates substrates other than
RNA. In vitro, bacterial Tpt1/KptA (from E. coli and S. coelicolor
SCO3953) robustly modifies 50-phosphorylated RNA, but not the
30-phosphorylated RNA [98]. The same activity is observed in
archaeal and fungal homologues [99]. It is, at this point, not clear
how this might be physiologically relevant but suggests that the
bacterial system is more versatile and plastic that we might have
assumed. Because Tpt1 is inessential in exemplary bacterial and
mammalian taxa, Tpt1 is seen as an attractive antifungal target
(essential in Fungi and Ascomycota) [100–101].
The overall structure and catalytic activity of Tpt1-like proteins
can be best described on Tpt1 protein from Clostridium thermocel-
lum. It consists of two globular domains, an N-terminal and a C-
terminal domain connected by a long loop (represented together
as a PTS_2-RNA domain in Table 1). N-domain has the winged helix
motif (helix-turn-helix family), which is shared by many DNA-
binding and some RNA-binding proteins [102]. C-domain consists
of two antiparallel b-sheets surrounded by five a-helices, which
superimposes well on NAD+-binding fold of bacterial (DTX-like)
toxins. The characteristic motif of Tpt1/KptA is H-H-h (with h being
a hydrophobic residue (Fig. 2)), while the catalytic activity is car-
ried out by four residues – RH-R-R conserved in all Tpt1-like pro-
teins (Fig. 3C). The reaction mechanism is carried out in two
steps: first, 20-phosphate of tRNA performs a nucleophilic attack
on C1‘‘ of distal ribose in NAD+ forming a 2’-phospho-ADP-
ribosylated RNA intermediate and expelling nicotinamide; second,
transesterification of the distal ADPr 2’–OH to the tRNA 2’-
phosphate displaces the tRNA product and generates ADPr 1‘‘,2‘‘-
cyclic phosphate [100,103–105].
CC0527 protein from Caulobacter crescentus has a DUF952
domain (Table 1) and shares a similar structure with the Tpt1 C-
terminal domain (RMSD between 31 pruned atom pairs is
0.911 Å) although has a very low sequence identity (11.3%). Its
active site architecture is characterized by the H-H-h motif. The
conserved H and alcoholic residue usually found within an HX[S/
T] motif often make polar contacts with the 20- and 30-OH of prox-
imal ribose. The hydrophobic residue (h) is found in the proximity
of the distal ribose. CC0527 gene is sporadically distributed in bac-
teria (around 1% of the 200 000 sequenced genomes (RefSeq) and
in [2]). Although the structure of C. crescentus CC0527 is available
(Fig. 3D), its function remains obscure. Aravind and colleagues sug-
gested by the rule of ‘‘guilt by association” (where CC0527 sits in
operons with genes related to antibiotic ADP-ribosylation) that
CC0527 ADP-ribosylates antibiotics or other toxic compounds,
probably in a reaction similar to the rifampin ARTs [2,106].
2.3.2. 6b/RolB ART
The 6b protein from Rhizobium radiobacter (formerly Agrobac-
terium rhizogenes, plant pathogen) is distantly related to the RolB
family proteins. The RolB gene has an elusive function in R. rhi-
zogenes hairy root disease in plants [107]. The 6b structure
adopts an ART toxin fold closely related to CTX and ExoA. The
ART activity is seen in vitro, but only in the presence of the host
Arabidopsis protein ARF, and GTP. The 6b represents a new toxin
family, with Y-T-Y-Y (Tyr66, Thr93, Tyr121 and Tyr153) as the2375ADP-ribosylation catalytic residues [2,108] (Table 1, Fig. 3J).
The 6b protein interacts with many different host proteins
implicated in plant cell proliferation. Transgenic Arabidopsis
plants expressing the 6b gene display morphological defects,
and more closely, a microRNA (miRNA) deficiency phenotype,
meaning 6b could target miRNA processing and splicing machin-
ery [108].3. Sirtuins
Sirtuins are enzymes found in all kingdoms of life. The first sir-
tuin found was the yeast Sir2, identified as a silencing factor
(silencing information regulator) with mild ADP-ribosylation activ-
ity [109]. The best-studied sirtuins are the seven mammalian
homologues (SIRT 1–7) that seem to act primarily as NAD+-
dependent deacetylases involved in fundamental processes such
as metabolic homeostasis and genome integrity [110]. Later they
were found to also remove a wide variety of acyl moieties includ-
ing butyryl, glutaryl, propionyl-lysine, succinyl and others [111].
Some of them (human SIRT4, 6 and 7) were shown to have addi-
tional ART activity by attaching the ADPr moiety to the e-amine
of lysine [109,112] (Fig. 1).
The Sir2 homologues are widespread in bacteria (around 2% of
200 000 genomes sequenced (RefSeq)). E. coli and Salmonella typhi-
murium LT2 Sir2 homologues, CobB, were identified as enzymes
involved in cobalamin synthesis via its weak ART activity towards
a small molecule 5,6-dimethylbenzimidazole, in addition to its
robust protein deacetylase activity [113–114].
Better studied in the context of ADP-ribosylation is the
Mycobacterium smegmatis SIRT4 (MsSIRT4) which exhibits a robust
auto ADP-ribosylation activity on arginine (probably Arg33). Stud-
ies on the MsSIRT4 deletion mutant showed growth retardation on
minimal medium, and the gene transcription was dramatically
induced in the wild type strain in the same conditions, suggesting
an important role of MsSIRT4 in fundamental metabolism and
growth [115].
Structurally, sirtuins are comprised of a highly conserved Ross-
mann fold (six parallel b-strands forming an extended b-sheet,
found in NAD+-binding enzymes) and a more diverse zinc coordi-
nating domain (Fig. 3H). Substrate specificity of sirtuins relies on
what seems much more than a sequence consensus of the target
[111]. The crystal structure of the Thermotoga maritima Sir2
(TmSir2) 17.8 kDa monomeric auto-MARylated protein (modified
on Asp56) [116] was resolved and gave an insight into the catalytic
mechanism. The reaction requires the right orientation of NAD+
and acetyl-lysine substrate which needs to be in a position to carry
out the nucleophilic attack on the C10 atom of distal ribose forming
the O-alkylamidate intermediate and releasing nicotinamide.
His116 acting as an acid and a base, respectively, ensures the
formation of two more subsequent intermediates. In the end,
water-mediated attack on last intermediate results with released
lysine substrate side chain and 20-O-acetyl ADPr (OAADPr). The
mechanism is explained in detail in [117].
A very distinct and diverged class of sirtuins that can be found
in pathogenic bacteria (e.g. Staphylococcus aureus and Streptococcus
pyogenes) are structurally similar to Sir2 (RMSD = 2.066 Å) (Fig. 3I)
but they share only 10.6% sequence identity. These sirtuins (SirTM)
come in operons with a specific subclass of macrodomain proteins,
which reverse the sirtuin catalysed ADP-ribosylation. SirTM-
mediated ADP-ribosylation is dependent on another posttransla-
tional modification — lipoylation. The two PTMs play a role in
microbial pathogens response to oxidative stress, which is often
used by their hosts as a potent defence mechanism [112]. SirTMs
will be discussed further in the context of the reversible ADP-
ribosylation systems.
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Two types of evolutionarily very distinct enzymes can reverse
the ADP-ribosylation modification – the macrodomain hydrolases
and the hydrolases related to ADP-ribosyl-(dinitrogen reductase)
glycohydrolase (DraG) [26]. Also, there are non-canonical ADPr
hydrolases [118–119]. The canonical a/b macrodomain fold con-
sists of six-stranded mixed b-sheet sandwiched by five a-helices.
Within the context of de-ADP-ribosylation, the macrodomain
group consist of the PAR-glycohydrolase (PARG), MacroD-like and
terminal ADPr glycohydrolase 1 (TARG1)-like hydrolases [120].
Canonical PARG cleaves the PAR-specific O-glycosidic ribose–ri-
bose bonds [4], but cannot hydrolyse the last protein-bound ADPr,
thus leaving a MARylated protein (Fig. 1). DraG-like enzymes in
eukaryotes (called ARHs) cleave MARylated proteins on arginine
and serine residues, the O-glycosidic bond of PAR chains and
OAADPr [121–123]. In eukaryotes both DraG-like and PARGs are
recruited to DNA damage sites and are reported to play important
parts in the DNA damage response [124–126]. MacroD- and
TARG1-like break the O-glycosidic ester bond of modified aspar-
tates, glutamates, and OAADPr, the reaction product of the NAD+-
dependent sirtuin deacetylases, as well as phosphate ester at
nucleic acid ends, thus cleaving off the final ADPr as well [98,120].4.1. Macrodomain family ARHs
4.1.1. Bacterial MacroD-like ARHs
MacroD homologues can be found in most bacteria [120]
(Table 3). The typical homologues contain the signature motifs
Nx(6)GG[V/L/I]D and G[V/I/A][Y/F]G (Fig. 2), and the catalytic duo
Asn174 and Asp184 (in human MACROD1) [127].
MacroD protein from Oceanobacillus iheyensis (deep-sea bac-
terium) is composed of a central seven-stranded mixed b-sheetFig. 4. 3D structures of bacterial and viral ARHs. (A) O. iheyensis macrodomain in com
PARG in complex with ADPr; (D) R. rubrum DraG in complex with ADPr - amino acids tha
not present in the crystal structure). ADPr is depicted as a stick model in yellow, and am
and (B) catalytically important water molecule is depicted as a ball model. (For interpreta
version of this article.)
2376sandwiched between the five a-helices which is very similar to
that found in other macrodomains [128] (Fig. 4A). The first pro-
posed catalytic mechanism requires three conserved residues:
asparagine that coordinates the nucleophilic water, tyrosine that
stabilizes the orientation of the distal ribose and aspartate which
deprotonates catalytic water molecule to attack carbonyl group
with concomitant hydrolysis of the acetyl group [128–131]. Inter-
estingly, the mutation of this aspartate residue does not manage to
completely abolish the enzyme activity, and not all MacroD-like
macrodomains possess such aspartate residue. This leads to a pro-
posal of a second, equally possible, substrate assisted mechanism,
in which water molecule tightly coordinated between Pa and distal
ribose is activated by the Pa group for nucleophilic attack on the
carbonyl carbon [128,132]. Mutation of glycine that positions this
water molecule led to a significant fall in catalytic efficiency and
proved that it is indispensable for the adequate conformation of
ADPr. This latter mechanism seems also to be one of the proposed
mechanisms for the catalytic mechanism of the viral macrodo-
mains from Coronaviridae which will be discussed in the next
chapter [133–134].
E. coli MacroD homologue, YmdB, appears to be a multifunc-
tional protein that regulates a variety of cellular processes;
deacetylates OAADPr, hydrolyses MARylated protein substrates,
regulates RNAse III activity and modulates bacterial biofilm forma-
tion [129,135–137]. The crystal structure of E. coli YmdB revealed
the catalytic duo made out of Asn25 and Asp35 and an active water
molecule which is proposed as the nucleophile to attack the acetyl
group of OAADPr [130].
The SCO6450 is an S. coelicolor MacroD orthologue. Besides its
activity on MARylated protein substrate, SCO6450 was found to
be active at reversing RNA MARylation mediated by both
SCO3953 (S. coelicolor homologue of the Tpt1) and the human
homologue TRPT1, as well as from MARylated phosphorylated
double-stranded DNA ends [98,138].plex with ADPr; (B) SARS-CoV-2 macrodomain in complex with ADPr; (C) T. curvata
t are important for binding of dinuclear Mn2+ centre are shown (second Mn2+ ion is
ino acids that are presumed to be important for catalysis are shown in green. In (A)
tion of the references to colour in this figure legend, the reader is referred to the web
P. Mikolčević, A. Hloušek-Kasun, I. Ahel et al. Computational and Structural Biotechnology Journal 19 (2021) 2366–23844.1.2. Viral MacroD-like ARHs
RNA viruses from families of Coronaviridae [139], Togaviridae
[140] and Hepeviridae [141] have macrodomain encoding genes
[134,142–144]. They come as a single domain or as a part of big
multidomain proteins [7,134]. Most of these viral macrodomains
are MacroD homologous [120], except the SARS coronavirus
(SARS-CoV) unique SUD macrodomains [120,145].
The viral macrodomains are linked to promoting viral replica-
tion and seem to play an important role in deflecting the host’s first
line of the immune response. Examples come from experiments in
bone-marrow-derived macrophage and murine models of murine
hepatitis and coronavirus infection. When infected with
catalytic-null or macrodomain (from murine hepatitis virus
(MHV), human coronavirus 229E (HCoV-229E) and SARS-CoV dele-
tion mutant strain, the viral replication and overall organ viral load
were lowered and generally produced milder symptoms [146–
148]. As a reaction to corona viral infection, the activity of human
antiviral PARPs (PARP9, 12 and 14) goes up and induces the pro-
inflammatory response in the cell. Viral macrodomains can reverse
this antiviral environment as seen in vitro for several viral macro-
domains from coronaviruses, alphaviruses and hepatoviruses using
the standard model MAR/PARylated substrates [7,133,146,149].
Another piece of evidence emphasizing the importance of
macrodomain-antiviral PARPs interactions comes from the evolu-
tionary study of macrodomains in mosquito alphaviruses. The
mosquitos lack the antiviral PARPs in their genomes and sequence
comparison of members of the mosquito-specific alphaviruses
with closely related alphaviruses of the western equine encephali-
tis complex revealed a specific loss of catalytically important resi-
dues within their macrodomain [134].
The SARS-CoV-2 virus, responsible for the COVID-19 infection
belongs to the family of betacoronaviruses and its macrodomain
is a part of the non-structural protein 3 (nsp3), a 200 kDa multido-
main protein [134,150] (Table 2). Many groups studied the crystal
structure and structural phylogenetic approach to define and
demonstrate its unique characteristics to enable the search for
the inhibitor of the SARS-CoV-2 macrodomain. It has been found
that the SARS-CoV-2 macrodomain presents several unique fea-
tures among which a distinct electrostatic microenvironment, as
well as specific residue functionalities and differences in the prox-
imal ribose binding area and catalytic pocket. Also, concerns have
been raised about the potential inhibitor targeting human or
human microbiome macrodomains. The sequence comparison of
the SARS-CoV-2 macrodomain with the human and human micro-
biome macrodomains showed the best fit with human PARP9 and
PARP14, and the Coronaviridae-like macrodomain from the human
microbiome Clostridium tyrobutyricum YmdB. None of these
sequences, however, showed similarities in the proximal ribose
binding area, identified as the macrodomain selective region. This
shows that alphavirus and SARS-like coronavirus macrodomains
can be selectively targeted without a high likelihood of cross-
reactivity with the human host or microbiome which lends further
argument as to why the viral macrodomains are valuable thera-
peutic targets [134,142,146,151–153].
The therapeutic potential of the SARS-CoV-2 macrodomain
started a rapid search for a potential inhibitor and led to a vast
number of crystal structures deposited in Protein Data Bank. Apo
form (PDB: 6WEY, 6VXS, 6WEN); complex with ADPr (PDB:
6 W02, 6Z5T, 6WOJ, 6YWL), AMP (PDB: 6W6Y), inhibitors of the
related PARG enzyme ADP-HPD and ADP-HPM (PDB: 6Z6I and
6Z72, respectively), MES (PDB: 6WCF, 6YWM) and HEPES (PDB:
6YWK). Also, an extensive fragment analysis resulted in 214 crystal
structures of SARS-CoV-2 macrodomain in complex with various
fragments [153]. This analysis gave extensive information about
different fragment binding that could lead to the design of poten-
tial specific inhibitors.2377While the catalytic mechanism of MacroD-like enzymes is not
fully understood, current evidence suggests a substrate-assisted
mechanism in which precise positioning of the distal ribose plays
an important role [129,132,134]. Crystal structures of SARS-CoV-
2 macrodomain in complex with ADPr revealed the presence of a
substrate-coordinated, activated water molecule placed between
the Gly48 and Pa, which was first discovered in a bacterial
MacroD-like enzyme [128]. This idea was tested by the introduc-
tion of a small side chain at Gly48 (G48V) which led to a reduction
in catalytic activity, supporting the idea that a substrate-activated
water molecule partakes in the reaction [26]. Amino acids pro-
posed to be involved in catalysis are shown in Fig. 4B.
4.1.3. Bacterial TARG1-like ARHs
TARG1 sequences are scarce (1% of total macrodomain
sequences) and only around thirty are found in sequenced bacterial
genomes, mostly in Firmicutes (84.8%) and Fusobacteria (6.1%)
phyla [154] (Table 3). It is a small, 17 kDa macrodomain protein
that occupies a distinct branch in the phylogenetic tree [120].
Despite its low sequence homology to MacroD-like proteins TARG1
exhibits a canonical core fold similar to other macrodomain pro-
teins but lacks the extended N- and C-terminal structural elements
found in MacroD. TARG1 catalytic duo encompasses Lys84 and
Asp125 in human TARG1 [155–156].
Using bioinformatics and phylogenetic analysis, Fusobacterium
mortiferum (usually pathogenic) TARG1 (FmTARG1) was recently
described. It is the first bacterial macrodomain protein shown to
be capable of deacetylating, de-MARylating and de-PARylating.
Its efficiency for OAADPr is even higher than human TARG1 and
other bacterial macrodomains (OiMAcroD, YmdB and Staphylococ-
cus aureus SAV0325). The FmTARG1 gene is located in a unique
operonic context, (found in Fusobacterium perfoetens as well),
which includes an immunity protein 51 domain, typical of bacte-
rial polymorphic toxin systems, making it a likely TA system [154].
S. coelicolor enzyme SCO6735 is a macrodomain protein that
groups into TARG1/ALC1 branch but lacks the catalytic duo, there-
fore the catalytic mechanism is probably unique for the SCO6735
macrodomain subclass. Nevertheless, in the in vitro assays,
SCO6735 can remove MARylation from glutamate residues. It
seems to be involved in DNA damage response as its expression
is under the control of RecA-independent DNA damage-inducible
promoter and upregulated upon UV-induced DNA damage
[21,157–158]. Also, disruption of SCO6735 increases the produc-
tion of actinorhodin antibiotic which indicates its possible regula-
tory role in antibiotic metabolism [21]. Our ongoing study tackles
the catalytic mechanism of SCO6735 by molecular dynamics sim-
ulations of the protein in complex with ADPr and cognate
substrate.
A specific macrodomain hydrolase that also belongs to this
group is the antitoxin DarG from TA system DarT/DarG, described
in more detail in the reversible ADP-ribosylation systems below.
4.1.4. Bacterial PARGs
Bacteria were historically considered to be devoid of PAR meta-
bolism, despite the fact many harbour genes homologous to the
eukaryotic PARPs and PARGs [3]. Many bacteria possess a distant
PARG homologue denoted as DUF2263 (Table 2 and 3). The first
solved crystal structure of such a protein was the one from Ther-
momonospora curvata (Fig. 4C). Comparison with the available
structures revealed an ADPr-binding macrodomain fold with a
novel type of N-terminal helical extension [4]. Its catalytic domain
belongs as a distant member of the macrodomain protein family. It
contains the PARG signature sequence (GGG-X6-8-QEE) with previ-
ously identified key residues: two consecutive glutamates (Fig. 2)
[4,159–160]. One of those signature glutamates mediates nucle-
ophilic attack of the putative oxocarbenium intermediate by a
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Indeed, several PARGs from different bacterial species (including
T. curvata (TcPARG) and H. aurantiacus (HaPARG)) can hydrolyse
PAR as seen in vitro [4].
TcPARG can bind only to the terminal residue of PAR polymers
because of the so-called ribose cap near its C-terminus. Therefore,
the bacterial-type PARGs are believed to be confined only to act as
exo-glycohydrolases. The eukaryotic, or canonical, PARGs share a
highly similar mechanism of hydrolysis of PAR with bacterial-
type PARGs but can process PAR in both endo- and exo-mode due
to the lack of such steric hindrance, i.e., the ribose cap [161]. Albeit,
the canonical PARGs have phenylalanine (Phe398 in Tetrahymena
thermophila; Phe902 in human PARG) [162] which positions next
to distal ribose and lowers the affinity to PAR in endo-mode,
restricting them to predominantly act as exo-glycohydrolases [34].
Recently, the Deinococcus radiodurans PARG (DrPARG), similar
to HaPARG and TcPARG, was also characterised [51]. The authors
observed that an extra n + 1 ADPr unit could fit in the protein sur-
face, likely due to the lack of mentioned steric hindrance. This was
corroborated by in vitro assays, proving that, in addition to the exo-,
the DrPARG also has an endo-glycohydrolase activity. Expression of
DrPARG is upregulated after radiation damage and endogenous
PAR was accumulated after UV damage. Recovery after was some-
what compromised in the DrPARG depletion strain [51]. Both, the
endo- and exo-activity and involvement in DNA damage response
make DrPARG very similar to human PARG [163].
PARG and MacroD homologue form a basic hydrolase duo that
accompanies PARPs from H. aurantiacus, C. difficile and Butyrivibrio
proteoclasticus (Table 3) ensuring complete de-PARylation. More-
over, B. proteoclasticus and H. aurantiacus possess one and even
more additional hydrolases, respectively. This diverse set of pro-
teins for complete functional PAR metabolism present in these bac-
teria are more likely an adaptive advantage that has been
preserved over time, rather than a simple horizontal gene transfer
event [50]. For H. aurantiacus it might reflect its specific way of life
as nature’s scavenger and a predator of other bacteria [164–165].
4.2. DraG-like family ARHs
DraG family of hydrolases is named after its founder DraG pro-
tein found in nitrogen-fixing bacteria. Its homologues are present
in all kingdoms of life. In bacteria, it is best studied in Azospirillum
brasilense and Rhodospirillum rubrum, where it regulates the nitro-
gen fixation metabolism. There are three DraG homologues
encoded in the human genome, ARH1-3 [26,121,166–167]. The
specificity of the well characterised DraG-like hydrolases is to
cleave the linkages to arginine and serine [168–169]. DraG acts
specifically towards MARylated substrates and is most probably
active as a monomer. Structures of the DraG from A. brasilense
and R. rubrum have been solved, and they have high structure sim-
ilarity (RMSD = 0.845 Å and 60% of sequence identity) [166,170–
171]. The crystal structure shows 15 all-a-helix architecture with
two magnesium ions located in the active site (although the pro-
tein shows the best activity when Mn2+ is bound) (Fig. 4D). Com-
parison of the A. brasilense DraG with other similar ARHs
(2FOZ,1T5J and 2CWC) shows that 13 of those helices define a
common a-helical core structure of the DraG family. Central
helices H3 and H13 carry the highly conserved asparagine and
threonine residues that are critical for Mn2+ binding. The binding
model shows that the manganese ions have a crucial role in posi-
tioning and activating the terminal ribose unit for nucleophilic
attack by a water molecule [166].
Based on experiments and crystal structure of DraG from R.
rubrum in complex with ADPr it was proposed that catalytic reac-
tion is initiated by opening of the ribose ring and formation of a
protonated Schiff base. This substrate opening leads to the shift2378in metal coordination, thus allowing the nucleophilic attack by a
water molecule activated by Mn2+ and resulting in a tetrahedral
intermediate. Finally, the proton transfer via Asp97 results in a bet-
ter leaving group, promoting intermediate collapse, releasing of
arginine and ring closure of an open ribose [171].
Since DraG comes in a pair with its cognate ART, the DraT, they
will be mentioned further in the reversible ADP-ribosylation sys-
tem context.5. Reversible ADP-ribosylation systems
Bacterial reversible ADP-ribosylation systems, in general,
encompass transferase/hydrolase pairs that work together, i.e.,
counteract each other, and lie in the same operon. They usually
represent a TA pair, where the toxin is aimed at the host/enemy
and the antitoxin is the antidote that protects the assailant, the
bacteria. TA systems are also considered important as a bacterial
persistence mechanism. Under stress conditions, the antitoxin is
inactivated leading to cell growth arrest due to toxin activation.
In favourable growth conditions, the antitoxin gets activated and
cell proliferation resumes. There are exceptions to these classical
TA systems, as exemplified by some of the systems explained
below.5.1. DraT/DraG
DraT/DraG is one of the earliest discovered ART/ARH pairs.
While DraT homologues are restricted to several nitrogen-fixing
bacteria, DraG homologues can be found in all three domains of life
[172].
The biological nitrogen fixation by conversion into ammonia is
highly energetically costly, therefore the system is tightly regu-
lated both on the transcriptional and post-translational level. The
DraT (dinitrogenase reductase ADPr transferase) MARylates the
Arg101 residue of the key enzyme in nitrogen fixation Fe protein
(dinitrogenase reductase) during the ‘‘switch-off” phase [173]
which prevents the formation of the nitrogenase complex and con-
sequently reduces nitrogen fixation. The ‘‘switch-off” state is
induced by high levels of ammonia or during low energy condi-
tions (due to light or oxygen deprivation) [174]. DraT activity is
counteracted by its neighbouring hydrolase DraG (see above)
residing in the same operon. The pair is simultaneously expressed
at low levels, but their activity is tightly regulated. DraG is inacti-
vated by sequestration to the bacterial plasma membrane and
becomes activated during the normal nitrogen fixation conditions
(while DraT is inactive) [80,175]. The fact that the pair is very
tightly regulated, and the DraT is highly efficient and specific for
the singular target, is reminiscent of the classical bacterial ART tox-
ins. Therefore, DraT/DraG can be considered a ‘‘domesticated” TA
system [2,176].
The structure for DraT is not available, probably due to its insta-
bility in vitro. It is known that it requires the presence of another
stabilizing/activating protein, a P protein. The activity of DraT is
similar to other bacterial toxin ARTs, and due to the conserved R-
S-E motif, it belongs to the CTX family [175] (Table 1 and Fig. 2).5.2. DarT/DarG
TA pair composed of DarT transferase and its cognate hydrolase
DarG have been found in, so far, only several various bacteria
including pathogens such as Mycobacterium tuberculosis and Kleb-
siella pneumoniae and opportunistic pathogen Pseudomonas men-
docina [177–179]. DarT/DarG is the first characterized system for
the reversible ADP-ribosylation of nucleic acids.
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(0.2% out of 200 000 bacterial genomes). It strictly MARylates the
single-stranded DNA on specific thymidine residues in the TNTC,
TTT or TCT motifs. The consequences of DarT MARylation is impair-
ment of cellular processes essential for bacterial growth and acti-
vation of the SOS response. The formation of the ADPr-DNA
adduct is reversed via the action of DarG, which shares some func-
tional features with human orthologue TARG1 [179]. In entero-
pathic E. coli, it was also shown that the MARylated DNA blocks
replication as the DNA-ADPr is perceived as DNA damage, suggest-
ing that host bacteria may exploit this system to induce persis-
tence [179–180]. DarG antitoxin activity is indispensable for
resuming growth and an essential gene when DarT is present
[180–181].
The DarG macrodomain adopts a typical macrodomain fold and
is structurally most similar to eukaryotic TARG1. Since these two
enzymes share de-MARylation activity and the overall shape of
the macrodomain ligand-binding pocket as well as the ligand posi-
tion, it was considered that they also share a catalytic activity. The
first proposed catalytic mechanism of TARG1 included the nucle-
ophilic attack of Lys84 on the ribose-C100 position and formation
of an open ring Amadori product, but further functional analysis
of Glu125 which makes catalytic duo with Lys84 [155] led to a pro-
posal of a second catalytic mechanism. Such a mechanism would
involve deprotonation of Lys84 by Glu125 and then a nucleophilic
attack that leads to the formation of a Schiff base. Further, a nucle-
ophilic attack of a water molecule activated by Glu125 leads to the
formation of ring-opened ADPr and enables regeneration of the
catalytic lysine [155,179]. DarG contains one of the catalytic duo
- residue Lys80 but lacks the glutamate equivalent (Fig. 2). Indeed,
the mutation of Lys80 in DarG showed the most significant effect
on substrate turnover out of all mutants tested and resulted in
inactive DarG indicating the importance of this conserved lysine
residue. Still, the complete catalytic mechanism remains elusive.
5.3. SirTM
A distinct class of sirtuins, SirTM, are found predominantly in
pathogenic bacteria. What clearly distinguishes them from other
sirtuins is a very robust ART activity and genetic linkage to a speci-
fic subclass of MacroD-like hydrolases, which reverse the sirtuin
catalysed ADP-ribosylation [112].
SirTMs in opportunistic pathogens Staphylococcus aureus and
Streptococcus pyogenes were described. The ART and macrodomain
hydrolase genes come in an operon with two more genes - modifi-
cation carrier protein (GcvH-L) and a lipoate ligase. The target pro-
tein GcvH-L is modified twice in sequential order - firstly by the
lipoate ligase (synthesising protein lipoylation) and then MARy-
lated by SirTM. The lipoylation is a prerequisite for the ART activity
of the SirTM. The key histidine residue and crucial for deacetylase
activity in all sirtuins is replaced by Gln137 in SirTMs. Mutation of
Gln137 in addition to Asn118 and Arg192 dramatically decreased
the catalytic activity, pointing to this as the SirTM catalytic trio
(Fig. 3I). The MARylation can be reversed by sirtuins-dependent
MacroD-like hydrolase [112]. They contain an extended catalytic
loop containing a zinc-binding motif instead of typical glycine-
rich stretch going into a-helix 6, and an amino acid exchange in
the catalytic loop. The Zn2+ found in the active site suggests it is
involved in the catalytic function which would be unique for the
members of this class of MacroD-like hydrolases [182].
The system establishes crosstalk between lipoylation and
MARylation and it is possible these PTMs together modulate
microbial virulence by regulating the response to host-derived
reactive oxygen species. SirTMs can be found in other pathogenic
bacteria (Clostridiaceae, Enterococcaceae, Lachnospiraceae, Spiro-
chaetaceae, and Veillonellaceae families) and fungi (Aspergillus,2379Candida, Entamoeba, Fusarium, and Phytophthora genera etc.)
[112].
5.4. ParT/ParS
The endotoxin module from Sphingobium sp. YBL2 ParT/ParS
functions as a TA system and is found in 18% of bacterial species.
The ParT is an unusually small ART (~18 kDa), which may mean
it is evolutionarily old. It contains the RES domain (Table 1),
although its typical triad motif R-Y-N differs from both DTX and
CTX family (Fig. 2). The alanine scan on the highly conserved resi-
dues Arg31, Glu52, and His56 resulted in the elimination of the
toxic phenotype, suggesting these to be the catalytic residues
(Fig. 3K). ParT specifically MARylates E. coli phosphoribosyl
pyrophosphate synthetase (Prs), an essential enzyme in nucleotide
biosynthesis conserved among all free-living organisms. Modifica-
tion sites are Lys182 (located in the ATP-binding site) or Ser202.
ParS counteracts the ParT activity through protein interaction inhi-
bition [183].
5.5. SidE/SidJ/DupA
A new class of ubiquitin targeting CTX family ARTs has been
described. The best-studied example is the human pathogenic bac-
terium Legionella pneumophila proteins, the SidE enzymes (SdeA,
SdeB, SdeC and SidE). Their activity can be counteracted at two
levels by SidJ, the calmodulin-dependent glutamylase and by DupA
and DupB, the two deubiquitinases [184–193]. The SdeA-C, SidJ
and the DupA reside within the same operon [192].
The full-length SdeA protein (best described of the SidE-type
enzymes) contains four domains: an N-terminal deubiquitinase
(DUB) domain, a phosphodiesterase (PDE) domain, a MARylating
ART domain (mART), and a C-terminal putative coiled-coil (CC)
domain (Table 1). The mART domain contains the R-S-[EXE] motif
with two conserved glutamates (Glu860 and Glu862) as key resi-
dues for enzymatic activity (Fig. 2). It transfers ADPr onto Arg42 of
ubiquitin (Ub) and the PDE domain cleaves the ADPr-Ub to
phosphoribosyl(PR)-Ub which is then conjugated to substrate ser-
ines. SidE enzymes target more than 180 different proteins within
the infected cells [192]. The most prominent ones are the Rab small
GTPases [186,194–195], reticulon-type ER membrane proteins
[201], mitochondrial proteins and Golgi components
[185,192,194]. The SidJ has been first proposed to act as a deubiqui-
tinase [186], but recent findings indicate that SidJ acts as a glutamy-
lase that inhibits SidE enzymes by targeting the catalytic site of their
mART domain [188–190]. The activity of SidJ is essential for its role
in L. pneumophila infection [186]. The actual reversing of the SidE
enzymes activity is performed by DupA and DupB, the deubiquiti-
naseswhich structurally resemble the PDEdomain of SdeA and SidE.
DupA/B PDE preference for deubiquitinating activity is governed by
their high interaction affinity and longer residence timeof the PR-Ub
substrate in comparison to that one of SidEs [192].
A similar to SdeA, Ub-specific ART CteC from Chromobacterium
violaceum specifically MARylates Thr66 of ubiquitin both in
mono- and poly-Ub state, which inhibits poly-Ub chain synthesis.
Two homologous proteins, CHBU from Burkholderia ubonensis and
CHCS from Corallococcus sp., show 66% and 24% sequence identity
with CteC, respectively, and the same activity. All three proteins
seem to have the R-S-E motif but otherwise show no predicted
structural similarity with the CTX family [196].
5.6. Tre1/Tri1
Tre1 (Type IV secretion ART effector 1) from Serratia proteamac-
ulans (insect pathogen) is the best-studied member of a small
group of bacterial ART which MARylate several bacterial proteins
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in operons containing an immunoprotein that can neutralize the
toxin via interaction and occlusion of the active site or by harbour-
ing an ARH domain. Among the targets are the proteins involved in
cell division (tubulin-like FtsZ), translation (EF-Tu), RNA metabo-
lism (RNase E), and lipoprotein transport (LoID). MARylation of
FtsZ by Tre1 was closely examined and it shows modification on
Arg174. The modification efficiently abolishes the FtsZ function
in Z-ring formation and cell division. Tre1 is a typical R-S-E ART
(Fig. 2), as the mutation of the glutamic acid abolishes its activity.
Its immunoprotein Tri1 has a two for one mode of protection; it
occludes the active site of Tre1 with its N-terminal extension and
has a DraG-like domain that reverses Tre1 ART activity (Table2
and Fig. 2). Upon closer analysis of other DraG-like immunity pro-
teins and their N-terminal extensions, the authors suggest these
dual immunity proteins might be quite common, especially among
Gram-negative bacteria [197].6. Conclusions
Almost 60 years of research on the ADP-ribosylation system has
yielded an enviable amount of knowledge, placing this system
right at the core of many essential pathways such as DNA-
damage repair, DNA replication, transcription, signal transduction,
cell division, stress and infection responses, microbial pathogenic-
ity, and ageing. While the focus was put primarily on the mam-
malian homologues, the bacterial world of ARTs, sirtuins and
ARHs, and more expanded, offering candidates for each type of
enzymes found in their evolutionarily higher counterparts, and
more. Bacterial and viral versions of ART, sirtuin, Macro, and
DraG-like domains in diverse conflict systems offer the potential
for understanding the nature of these conflict systems, the true
diversity of biochemical activities of the ADP-ribosylation system
and the possibility of new solutions to antimicrobial and viral
treatments. Despite the accumulated knowledge, one is left want-
ing more understanding of the molecular mechanisms governing
ADP-ribosylation signalling and the physiological and pathophysi-
ological importance of the pathways regulated by ADP-
ribosylation. Thus, we can expect much more exciting data to be
added to the pool of knowledge, including the current efforts of
tackling the search for an inhibitor of the viral macrodomain found
in the SARS-CoV-2 to fight the ongoing pandemic
[134,142,153,198]. Also, we do know that enzymatic reactions of
ADP-ribosylation are central in the pathogenesis of many human
diseases and infections. The post-antibiotic era has raised the need
to find alternative ways to fight pathogenic bacteria as major ones
are becoming resistant to the existing antibiotics. The newly found
in-depth understanding of ADP-ribosylation reactions will provide
the rationale for designing novel antimicrobial strategies for the
treatment of current and future infectious diseases.CRediT authorship contribution statement
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